VYYRF (Voyageur Pharmaceuticals) Cyclically Adjusted PB Ratio: (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VYYRF Voyageur Pharmaceuticals Ltd VYYRF
17 GF Score
Price $0.10
! 5 Warning Signs
View Full Analysis

What is Voyageur Pharmaceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Voyageur Pharmaceuticals  (OTCPK:VYYRF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Voyageur Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms


Voyageur Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Voyageur Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Voyageur Pharmaceuticals Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.07 1.79 1.25 2.45 6.96

Voyageur Pharmaceuticals Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.61 6.88 6.96 7.27 3.97

VYYRF vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voyageur Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


VYYRF
17GF Score
Voyageur Pharmaceuticals Ltd VYYRF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyageur Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Voyageur Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in May. 2026 is calculated as:

For example, Voyageur Pharmaceuticals's adjusted Book Value per Share data for the three months ended in May. 2026 was:

Adj_Book=Book Value per Share/CPI of May. 2026 (Change)*Current CPI (May. 2026)
=0.002/134.0005*134.0005
=0.002

Current CPI (May. 2026) = 134.0005.

Voyageur Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.022 102.002 0.029
201609 0.019 101.765 0.025
201612 0.218 101.449 0.288
201705 0.000 103.108 0.000
201708 -0.003 103.108 -0.004
201711 -0.002 103.740 -0.003
201802 0.001 104.688 0.001
201805 0.001 105.399 0.001
201808 0.008 106.031 0.010
201811 0.007 105.478 0.009
201902 0.005 106.268 0.006
201905 0.006 107.927 0.007
201908 0.008 108.085 0.010
201911 0.009 107.769 0.011
202002 0.011 108.559 0.014
202005 0.008 107.532 0.010
202008 0.005 108.243 0.006
202011 0.003 108.796 0.004
202102 0.009 109.745 0.011
202105 0.021 111.404 0.025
202108 0.019 112.668 0.023
202111 0.015 113.932 0.018
202202 0.013 115.986 0.015
202205 0.009 120.016 0.010
202208 0.013 120.569 0.014
202211 0.009 121.675 0.010
202302 0.013 122.070 0.014
202305 0.010 124.045 0.011
202308 0.010 125.389 0.011
202311 0.008 125.468 0.009
202402 0.008 125.468 0.009
202405 0.007 127.601 0.007
202408 0.005 127.838 0.005
202411 0.002 127.838 0.002
202502 0.005 128.786 0.005
202505 0.004 129.813 0.004
202508 0.006 130.208 0.006
202511 0.005 130.682 0.005
202602 0.003 131.077 0.003
202605 0.002 134.001 0.002

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Voyageur Pharmaceuticals Business Description

Other Exchanges VM:Canada
Address 4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
17GF Score

Get the complete analysis for VYYRF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price